Evidence map›Paper›PMID 26934372›Full record

Trial reportPloS one2016

Immunization Coverage Surveys and Linked Biomarker Serosurveys in Three Regions in Ethiopia.

Mark A Travassos, Berhane Beyene, Zenaw Adam, James D Campbell, Nigisti Mulholland, Seydou S Diarra, Tassew Kassa, Lisa Oot, Jenny Sequeira, Mardi Reymann and 9 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
4.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. mBio · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 3 countries.

Mark A TravassosCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Berhane BeyeneEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Zenaw AdamJSI Research & Training Institute Inc., Arlington, Virginia, United States of America.
James D CampbellCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Nigisti MulhollandDepartment of Social Work, The Women's Hospital, Melbourne, Australia.
Seydou S DiarraCentre pour le Développement des Vaccins, Mali (CVD-Mali), Bamako, Mali.
Tassew KassaEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Lisa OotJSI Research & Training Institute Inc., Arlington, Virginia, United States of America.
Jenny SequeiraJSI Research & Training Institute Inc., Arlington, Virginia, United States of America.
Mardi ReymannCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
William C BlackwelderCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Yukun WuCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Inna RuslanovaCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Jaya GoswamiCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Samba O SowCentre pour le Développement des Vaccins, Mali (CVD-Mali), Bamako, Mali.
Marcela F PasettiCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Robert SteinglassJSI Research & Training Institute Inc., Arlington, Virginia, United States of America.
Amha KebedeEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Myron M LevineCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
University of Maryland, Baltimore · USEthiopian Public Health Institute · ETCentre Pour le Développement des Vaccins-Mali · ML

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveDemographic and health surveys, immunization coverage surveys and administrative data often divergently estimate vaccination coverage, which hinders pinpointing districts where immunization services require strengthening. We assayed vaccination coverage in three regions in Ethiopia by coverage surveys and linked serosurveys.

methodsHouseholds with children aged 12-23 (N = 300) or 6-8 months (N = 100) in each of three districts (woredas) were randomly selected for immunization coverage surveys (inspection of vaccination cards and immunization clinic records and maternal recall) and linked serosurveys. IgG-ELISA serologic biomarkers included tetanus antitoxin ≥ 0.15 IU/ml in toddlers (receipt of tetanus toxoid) and Haemophilus influenzae type b (Hib) anti-capsular titers ≥ 1.0 mcg/ml in infants (timely receipt of Hib vaccine).

findingsCoverage surveys enrolled 1,181 children across three woredas; 1,023 (87%) also enrolled in linked serosurveys. Administrative data over-estimated coverage compared to surveys, while maternal recall was unreliable. Serologic biomarkers documented a hierarchy among the districts. Biomarker measurement in infants provided insight on timeliness of vaccination not deducible from toddler results.

conclusionNeither administrative projections, vaccination card or EPI register inspections, nor parental recall, substitute for objective serological biomarker measurement. Including infants in serosurveys informs on vaccination timeliness.

Indexed as

Bacterial CapsulesBiomarkersDiphtheria-Tetanus-Pertussis VaccineEthiopiaFemaleHaemophilus VaccinesHealth SurveysHumansImmunizationImmunization ProgramsImmunization ScheduleImmunoglobulin GInfantMaleParentsVaccinationBiomarkersDiphtheria-Tetanus-Pertussis VaccineHaemophilus influenzae type b polysaccharide vaccineHaemophilus VaccinesImmunoglobulin G

Identifiers

PMID26934372
PMCPMC4774907
OpenAlexW2294201179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.